Clinical trialNCT02260388CompletedPhase 4Interventional

Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations

SponsorUniversity of Kansas Medical CenterEnrollment402Cryptogenic Sensory Polyneuropathy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this large comparative effectiveness study led by Richard J. Barohn, MD, of the University of Kansas Medical Center, is to learn about the safety and effectiveness of nortriptyline, duloxetine, pregabalin and mexiletine in treating cryptogenic sensory polyneuropathy (CSPN).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Richard Barohn, MD
University of Kansas Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Toronto General Hospital
Toronto, Ontario, Canada

United States

Barrow Neurological Institute
Phoenix, Arizona, United States
Phoenix Neurological Associates
Phoenix, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
California Pacific Medical Center
San Francisco, California, United States
University of California San Francisco
San Francisco, California, United States
University of Colorado Denver Anschutz Campus
Aurora, Colorado, United States
Colorado Springs Neurological Associates
Colorado Springs, Colorado, United States
University of Florida - Gainesville
Gainesville, Florida, United States
University of Florida Health Science Center - Jacksonville
Jacksonville, Florida, United States
University of Miami Miller School of Medicine
Miami, Florida, United States
Neurological Services of Orlando Research
Orlando, Florida, United States
University of South Florida
Tampa, Florida, United States
Northshore Neurological Institute
Glenview, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Hutchinson Clinic, Pa
Hutchinson, Kansas, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Norton Neurology Services
Louisville, Kentucky, United States
Brigham and Women'S Hospital
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Henry Ford Hospital
Detroit, Michigan, United States
Spectrum Health System
Grand Rapids, Michigan, United States
University of Minnesota
Minneapolis, Minnesota, United States
Saint Louis University
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
University of Buffalo School of Medicine and Biomedical Sciences
Buffalo, New York, United States
Mount Sinai Beth Israel
New York, New York, United States
University of Cincinnati
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
Penn State Medical Center
Hershey, Pennsylvania, United States
Austin Neuromuscular Center
Austin, Texas, United States
Sara Austin, Md, Pa
Austin, Texas, United States
Seton Brain and Spine Institute
Austin, Texas, United States
Texas Neurology
Dallas, Texas, United States
University of Texas Southwestern
Dallas, Texas, United States
University of Texas Health Science Center at Houton
Houston, Texas, United States

6 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Duloxetine →Mexiletine →Nortriptyline →Pregabalin →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2014
Primary completion: 30 Sept 2017
Completion: 30 Sept 2017
Last update posted: 6 Jul 2018
Registered enrollment: 402
Registry id: NCT02260388

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.